Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 19, 2022

Mayne Pharma Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MAYNE PHARMA INC, and what generic and branded alternatives to MAYNE PHARMA INC drugs are available?

MAYNE PHARMA INC has twenty-six approved drugs.

There is one tentative approval on MAYNE PHARMA INC drugs.

Summary for Mayne Pharma Inc

US Patents:	0
Tradenames:	22
Ingredients:	22
NDAs:	26

Drugs and US Patents for Mayne Pharma Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mayne Pharma Inc	BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE	brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride	SYRUP;ORAL	207676-001	Dec 4, 2018	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
Mayne Pharma Inc	HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE	chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride	SOLUTION;ORAL	205657-001	Aug 3, 2015		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Mayne Pharma Inc	OXYCODONE AND ASPIRIN	aspirin; oxycodone hydrochloride	TABLET;ORAL	091670-001	Mar 16, 2011		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Mayne Pharma Inc	EXEMESTANE	exemestane	TABLET;ORAL	208764-001	Aug 8, 2019		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Mayne Pharma Inc	AMIODARONE HYDROCHLORIDE	amiodarone hydrochloride	TABLET;ORAL	075389-003	Dec 28, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Mayne Pharma Inc	BUTALBITAL, ACETAMINOPHEN AND CAFFEINE	acetaminophen; butalbital; caffeine	CAPSULE;ORAL	089007-001	Mar 17, 1986	AA	RX	No	Yes		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Mayne Pharma Inc

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mayne Pharma Inc	SOLTAMOX	tamoxifen citrate	SOLUTION;ORAL	021807-001	Oct 29, 2005	6,127,425	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Boehringer Ingelheim

McKinsey

Express Scripts

Dow

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.